您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。 [美股财报]:Sotera Health Co 2025年度报告 - 发现报告

Sotera Health Co 2025年度报告

2026-04-08 美股财报 Lee
报告封面

Our Commitment toSafeguarding Global Health® Sotera Health Company (Nasdaq: SHC) is a leading global providerof mission-critical end-to-endsterilization solutions, lab testing and advisory services for the healthcare industry. The name, SoteraHealth, was inspired by Soteria, the Greek goddess of safety, and reflects the Company’s unwaveringcommitment to its mission, Safeguarding Global Health®. Company Highlights Globalcustomer base in50+ countries Over3,000employees acrossthe globe 90+years of sterilizationand lab services Network of63global facilities Our Three Businesses locations~3,000customers 49locations2,000+ Living Our Mission Every Day At Sotera Health, we are steadfast in our commitment to our mission,Safeguarding Global Health®. Our work helps to ensure the safety ofmillions of patients and healthcare workers around the globe, as well as thecommunities in which we operate and our 3,000+ global team members.While our high-quality testing, safe and reliable sterilization services andCobalt-60 supply expertise enable the safety of the global healthcareindustry, it is our team’s commitment to living our mission every day thatmakes an extraordinary difference. Our Values SAFETY We are uncompromising in our commitment to healthand well-being. CUSTOMER FOCUS We are driven to fulfill our customers’ needs with thehighest quality and care. PEOPLE We value our people who are part of a global team thatis diverse, respectful, passionate and collaborative. INTEGRITY We are honest, reliable and accountable ineverything we do. EXCELLENCE We exceed the expectations of our stakeholdersand continue to improve and innovate ineverything we do. A Letterfrom Our CEO Michael B. Petras, Jr. Dear Stockholders, Chairman and Chief Executive Officer As the global healthcare ecosystem continuesto evolve, Sotera Health’s role has becomeincreasingly vital and our opportunity morecompelling. Over the past year, we have remainedunwavering in our commitment to our mission –Safeguarding Global Health®– and to operatingwith excellence in an increasingly complex globallandscape. Our strategy is clear. Our team is aligned.We are optimistic about our future. Across Sterigenics, Nordion and Nelson Labs, our teams deliveredresults that reinforce our ability to operate with discipline,continuously improve and meet increased customer needs: •Sterigenicsdelivered strong, high-single-digit revenuegrowth in 2025, expanded volume and mix, and progressedmajor strategic initiatives, including ethylene oxide facilityenhancements and construction of our new X-ray facility,which opened in 2026. •Nordionalso delivered a strong year with high-single-digitrevenue growth, signed a new once-in-a-generation cobaltdevelopment agreement and secured a historic 25-year Class1B site license renewal – demonstrating both our regulatoryleadership and deep customer trust. A Global Leader Positionedfor Sustainable Growth We remain firmly positioned as aglobal leader in a rapidlyexpanding healthcare market, underpinned by strongdemand, expanding regulatory complexity and growingexpectations from customers who rely on us every day. Ourglobal footprint, comprised of a network of 63 facilities andlaboratories, places us in close proximity to our customersand enables end-to-end value. •Nelson Labsadvanced core lab testing, significantly improvedmargins and continued its investment in cleanroominfrastructure to support future growth. Safety remains non-negotiable.High stakes drive highexpectations. We invest in training, systems and engineeringcontrols to maintain a safe work environment and to meet orexceed regulatory expectations across jurisdictions. We continueto modernize equipment and implement technologies designedtoreduce emissionsbeyond what is required. With a growing addressable market exceeding$18 billion,and opportunities of more than$45 billionacross adjacentsegments, we are strategically aligned to capture above-market growth and deliver long-term value creation. Our team’s unwavering focus on operational excellence remainsfoundational as we execute on our long-range plan. Driving Consistent Growth ThroughOperational Excellence Supporting Customers andSafeguarding Global Health® Our performance over the past year reflects both thedurability of our business model and the strength of ourexecution. In 2025, we extended our track record of revenuegrowth to a20thconsecutive year, while expanding marginsand accelerating free cash flow generation. The healthcare companies we serve depend on us to ensurethe safety, reliability and readiness of products that protectand improve lives every day.Our customer satisfactionexceeded 80%this year – evidence of the trust we haveearned by delivering with consistency, quality, expertise anda partnership mindset. We are united by a common purpose –a global leader positionedfor sustainable growth, delivering compounding value whileadvancing our mission ofSafeguarding Global Health®. We